The pharmaceutical giant AstraZeneca has announced the global withdrawal of its COVID-19 vaccine, Covishield, mere weeks after acknowledging rare side effects associated with the shot. The decision, outlined in a report by The Telegraph, cites commercial reasons for the removal from markets worldwide. The vaccine, developed in collaboration with the University of Oxford, was once hailed as a beacon of hope in the fight against the pandemic.
Covishield, manufactured and supplied by the Serum Institute of India (SII), played a pivotal role in vaccination drives across low-and-middle-income countries. However, concerns over its safety have loomed large following reports of adverse reactions, including Thrombosis with Thrombocytopenia Syndrome (TTS), a condition causing blood clots and low blood platelet count.
The application to withdraw the vaccine, submitted on March 5 and effective as of Tuesday, comes amidst mounting legal challenges. A class action lawsuit alleges that AstraZeneca's vaccine led to deaths and serious injuries, with plaintiffs claiming damages of up to £100 million. Despite the company's admission of rare side effects, it vehemently denies any link between the withdrawal and the ongoing court case.
𝒇𝒐𝒓 𝒎𝒐𝒓𝒆 𝒅𝒆𝒕𝒂𝒊𝒍𝒔👇👇👇
https://lnkd.in/gxSJEN58
#AstraZeneca #Covishield #VaccineWithdrawal #COVID19 #SafetyConcerns
Congratulations Aisling Caffrey & team !